retatrutide dosage phase 2 trial clinical dosing retatrutide Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a Trial Data Dosing Schedule : – Retatrutide Dosing Guide: 2mg–12mg Protocol

Cohort 1 (n=7 males, 9 females) was used for Experiment 1 and cohort 2 (n=7 males, 3 females) was used in Experiments 2-4

In many cases, the term microdosing is used loosely and may refer to unsupervised or nonstandard dosing practices rather than medically guided titration

In March 2026, a Foundayo is notable not only for its oral formulation but also for being among the first medications approved under the FDAs new Additionally, unlike other oral GLP-1s, it does not require the fasting and water restrictions associated with oral semaglutide, potentially making it more accessible

Even though there have been no studies evaluating this approach, its something we definitely see in clinical practice. Who should consider microdosing GLP-1s